General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

General practitioners choose within a narrow range of drugs when initiating new treatments : a cohort study of cardiovascular drug formularies. / Buusman, Allan; Kragstrup, Jakob; Andersen, Morten.

In: European Journal of Clinical Pharmacology, Vol. 61, No. 9, 10.2005, p. 651-656.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Buusman, A, Kragstrup, J & Andersen, M 2005, 'General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies.', European Journal of Clinical Pharmacology, vol. 61, no. 9, pp. 651-656. https://doi.org/10.1007/s00228-005-0973-y

APA

Buusman, A., Kragstrup, J., & Andersen, M. (2005). General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies. European Journal of Clinical Pharmacology, 61(9), 651-656. https://doi.org/10.1007/s00228-005-0973-y

Vancouver

Buusman A, Kragstrup J, Andersen M. General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies. European Journal of Clinical Pharmacology. 2005 Oct;61(9):651-656. https://doi.org/10.1007/s00228-005-0973-y

Author

Buusman, Allan ; Kragstrup, Jakob ; Andersen, Morten. / General practitioners choose within a narrow range of drugs when initiating new treatments : a cohort study of cardiovascular drug formularies. In: European Journal of Clinical Pharmacology. 2005 ; Vol. 61, No. 9. pp. 651-656.

Bibtex

@article{10b5b8d46be844638b7157394ceeaaa8,
title = "General practitioners choose within a narrow range of drugs when initiating new treatments: a cohort study of cardiovascular drug formularies.",
abstract = "OBJECTIVE: The aims of this study were (1) to develop and evaluate a new method for investigating personal drug formularies in general practice and (2) to test the hypothesis that there is a difference between personal drug formularies for incident and ongoing drug use. METHODS: In 2002, we studied prescribing patterns of beta-blockers, calcium channel blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin-II antagonists and statins in the County of Funen, Denmark (180 general practices, 472,000 inhabitants). For each practice, we distinguished between an incident drug formulary consisting of prescriptions for new users and an ongoing drug formulary including prescriptions for patients already in treatment. Prescription data were retrieved from the Odense University Pharmacoepidemiologic Database (OPED). Four different formulary measures were evaluated and used for comparing incident and ongoing drug use. RESULTS: General practitioners' (GPs') incident drug formularies comprised significantly fewer drugs than their ongoing drug formularies for all drug groups except angiotensin-II antagonists. The difference in the total number of drugs used was between 1.8 and 3.3. We found differences between 0.5 and 1.6 analogues in the DU 90% (number of analogues accounting for 90% of the prescribed volume measured in defined daily doses) segment and the formulary selectivity index between 0.05 and 0.12. The preference for the most prescribed analogue was 9-18% higher among incident patients. The formulary selectivity index was highly correlated with the other formulary measures and quantified both range and skewed distribution of drug choice. CONCLUSION: Analysing GPs' prescriptions to incident patients is a simple and inexpensive method for studying their own current personal drug formularies. GPs choose within a narrow range of analogues for incident patients.",
author = "Allan Buusman and Jakob Kragstrup and Morten Andersen",
note = "Funding Information: Acknowledgements The authors wish to thank secretary Lise Stark for proofreading the manuscript and Chief, R&D unit Thorsten Kruse, Health Services Administration of the County of West-Zealand, for inspiring discussions. The study was funded by The Regional Institute for Health Sciences (grant no. 2002/10) and the Danish Research Foundation for General Practice (grant no. 70.205). The study complies with current laws in Denmark.",
year = "2005",
month = oct,
doi = "10.1007/s00228-005-0973-y",
language = "English",
volume = "61",
pages = "651--656",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer",
number = "9",

}

RIS

TY - JOUR

T1 - General practitioners choose within a narrow range of drugs when initiating new treatments

T2 - a cohort study of cardiovascular drug formularies.

AU - Buusman, Allan

AU - Kragstrup, Jakob

AU - Andersen, Morten

N1 - Funding Information: Acknowledgements The authors wish to thank secretary Lise Stark for proofreading the manuscript and Chief, R&D unit Thorsten Kruse, Health Services Administration of the County of West-Zealand, for inspiring discussions. The study was funded by The Regional Institute for Health Sciences (grant no. 2002/10) and the Danish Research Foundation for General Practice (grant no. 70.205). The study complies with current laws in Denmark.

PY - 2005/10

Y1 - 2005/10

N2 - OBJECTIVE: The aims of this study were (1) to develop and evaluate a new method for investigating personal drug formularies in general practice and (2) to test the hypothesis that there is a difference between personal drug formularies for incident and ongoing drug use. METHODS: In 2002, we studied prescribing patterns of beta-blockers, calcium channel blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin-II antagonists and statins in the County of Funen, Denmark (180 general practices, 472,000 inhabitants). For each practice, we distinguished between an incident drug formulary consisting of prescriptions for new users and an ongoing drug formulary including prescriptions for patients already in treatment. Prescription data were retrieved from the Odense University Pharmacoepidemiologic Database (OPED). Four different formulary measures were evaluated and used for comparing incident and ongoing drug use. RESULTS: General practitioners' (GPs') incident drug formularies comprised significantly fewer drugs than their ongoing drug formularies for all drug groups except angiotensin-II antagonists. The difference in the total number of drugs used was between 1.8 and 3.3. We found differences between 0.5 and 1.6 analogues in the DU 90% (number of analogues accounting for 90% of the prescribed volume measured in defined daily doses) segment and the formulary selectivity index between 0.05 and 0.12. The preference for the most prescribed analogue was 9-18% higher among incident patients. The formulary selectivity index was highly correlated with the other formulary measures and quantified both range and skewed distribution of drug choice. CONCLUSION: Analysing GPs' prescriptions to incident patients is a simple and inexpensive method for studying their own current personal drug formularies. GPs choose within a narrow range of analogues for incident patients.

AB - OBJECTIVE: The aims of this study were (1) to develop and evaluate a new method for investigating personal drug formularies in general practice and (2) to test the hypothesis that there is a difference between personal drug formularies for incident and ongoing drug use. METHODS: In 2002, we studied prescribing patterns of beta-blockers, calcium channel blockers, angiotensin converting enzyme (ACE) inhibitors, angiotensin-II antagonists and statins in the County of Funen, Denmark (180 general practices, 472,000 inhabitants). For each practice, we distinguished between an incident drug formulary consisting of prescriptions for new users and an ongoing drug formulary including prescriptions for patients already in treatment. Prescription data were retrieved from the Odense University Pharmacoepidemiologic Database (OPED). Four different formulary measures were evaluated and used for comparing incident and ongoing drug use. RESULTS: General practitioners' (GPs') incident drug formularies comprised significantly fewer drugs than their ongoing drug formularies for all drug groups except angiotensin-II antagonists. The difference in the total number of drugs used was between 1.8 and 3.3. We found differences between 0.5 and 1.6 analogues in the DU 90% (number of analogues accounting for 90% of the prescribed volume measured in defined daily doses) segment and the formulary selectivity index between 0.05 and 0.12. The preference for the most prescribed analogue was 9-18% higher among incident patients. The formulary selectivity index was highly correlated with the other formulary measures and quantified both range and skewed distribution of drug choice. CONCLUSION: Analysing GPs' prescriptions to incident patients is a simple and inexpensive method for studying their own current personal drug formularies. GPs choose within a narrow range of analogues for incident patients.

UR - http://www.scopus.com/inward/record.url?scp=33745731777&partnerID=8YFLogxK

U2 - 10.1007/s00228-005-0973-y

DO - 10.1007/s00228-005-0973-y

M3 - Journal article

C2 - 16187132

AN - SCOPUS:33745731777

VL - 61

SP - 651

EP - 656

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 9

ER -

ID: 324150310